Literature DB >> 12905134

Aeromonas infection of the hepatobiliary system: report of 15 cases and review of the literature.

Nina M Clark1, Carol E Chenoweth.   

Abstract

Aeromonas species cause both intestinal and extraintestinal disease. We reviewed hospital laboratory and medical records to identify patients with Aeromonas infection of the hepatobiliary or pancreatic system. Analysis of data from our hospital, as well as a review of the published literature, yielded a total of 41 episodes in 39 patients, and the features of these episodes are described. The most common manifestation of Aeromonas hepatobiliary infection among all reported cases was cholangitis (29 of 41 episodes). The majority of infections in our hospital occurred in patients with underlying immunosuppression or malignancy (13 of 15 patients), including 4 liver transplant recipients, and nosocomial infection was not infrequent (8 of 17 episodes). Infection occurred most commonly in patients with obstruction of the biliary tract due to stones, tumor, or stricture and was associated with a relatively high mortality rate (11.8%). Antibiotic susceptibility testing revealed that gentamicin, imipenem, and ciprofloxacin had the highest activity against the Aeromonas species isolated.

Entities:  

Mesh:

Year:  2003        PMID: 12905134     DOI: 10.1086/376629

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Evaluation of two miniaturized systems, MicroScan W/A and BBL Crystal E/NF, for identification of clinical isolates of Aeromonas spp.

Authors:  L Soler; F Marco; J Vila; M R Chacón; J Guarro; M J Figueras
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Prospective nationwide study of Aeromonas infections in France.

Authors:  Brigitte Lamy; Angeli Kodjo; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

3.  Biliary tract infections caused by Aeromonas species.

Authors:  C M Chao; C C Lai; H J Tang; W C Ko; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-24       Impact factor: 3.267

4.  Molecular characterization of a functional type VI secretion system from a clinical isolate of Aeromonas hydrophila.

Authors:  Giovanni Suarez; Johanna C Sierra; Jian Sha; Shaofei Wang; Tatiana E Erova; Amin A Fadl; Sheri M Foltz; Amy J Horneman; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

Review 5.  The genus Aeromonas: taxonomy, pathogenicity, and infection.

Authors:  J Michael Janda; Sharon L Abbott
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

6.  Severe sepsis caused by Aeromonas hydrophila in a patient using tocilizumab: a case report.

Authors:  Kenji Okumura; Fumihiro Shoji; Masaki Yoshida; Atsushi Mizuta; Ichiro Makino; Hidefumi Higashi
Journal:  J Med Case Rep       Date:  2011-10-05

7.  Aeromonas hydrophila Panophthalmitis in Pemphigus Vulgaris: A Case Report.

Authors:  Sukhumal Thanapaisal; Patsuda Thariya
Journal:  Case Rep Ophthalmol       Date:  2019-08-06

8.  Clinical significance and outcome of Aeromonas spp. infections among 204 adult patients.

Authors:  J Nolla-Salas; J Codina-Calero; S Vallés-Angulo; A Sitges-Serra; A Zapatero-Ferrándiz; M C Climent; J Gómez; J R Masclans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-03       Impact factor: 3.267

9.  Multifocal Aeromonas Osteomyelitis in a Child with Leukemia.

Authors:  Dimitrios Doganis; Margarita Baka; Maria Tsolia; Apostolos Pourtsidis; Evangelia Lebessi; Maria Varvoutsi; Despina Bouhoutsou; Helen Kosmidis
Journal:  Case Rep Infect Dis       Date:  2016-04-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.